Your browser doesn't support javascript.
loading
Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis.
Ammer-Herrmenau, Christoph; Antweiler, Kai L; Asendorf, Thomas; Beyer, Georg; Buchholz, Soeren M; Cameron, Silke; Capurso, Gabriele; Damm, Marko; Dang, Linh; Frost, Fabian; Gomes, Antonio; Hamm, Jacob; Henker, Robert; Hoffmeister, Albrecht; Meinhardt, Christian; Nawacki, Lukasz; Nunes, Vitor; Panyko, Arpad; Pardo, Cesareo; Phillip, Veit; Pukitis, Aldis; Rasch, Sebastian; Riekstina, Diana; Rinja, Ecaterina; Ruiz-Rebollo, María Lourdes; Sirtl, Simon; Weingarten, Mark; Sandru, Vasile; Woitalla, Julia; Ellenrieder, Volker; Neesse, Albrecht.
Afiliación
  • Ammer-Herrmenau C; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Antweiler KL; Department of Medical Statistics, University Medical Centre Goettingen, Goettingen, Germany.
  • Asendorf T; Department of Medical Statistics, University Medical Centre Goettingen, Goettingen, Germany.
  • Beyer G; Department of Medicine II, Ludwig Maximilians University Hospital, Munich, Germany.
  • Buchholz SM; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Cameron S; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Capurso G; Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Centre, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
  • Damm M; Internal Medicine I, University Hospital Halle, Halle, Germany.
  • Dang L; Department Medical Bioinformatics, University Medical Centre Goettingen, Goettingen, Germany.
  • Frost F; Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.
  • Gomes A; Department of General Surgery, Hospital Professor Doctor Fernando Fonseca, Amadora, Amadora, Portugal.
  • Hamm J; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Henker R; Medical Department II, Division of Gastroenterology, University Hospital Leipzig, Leipzig, Germany.
  • Hoffmeister A; Medical Department II, Division of Gastroenterology, University Hospital Leipzig, Leipzig, Germany.
  • Meinhardt C; University Clinic of Internal Medicine - Gastroenterology, University Hospital Oldenburg, Oldenburg, Germany.
  • Nawacki L; Collegium Medicum, The Jan Kochanowski University in Kielce, Kielce, Poland.
  • Nunes V; Department of General Surgery, Hospital Professor Doctor Fernando Fonseca, Amadora, Amadora, Portugal.
  • Panyko A; 4th Department of Surgery, University Hospital Bratislava, Bratislava, Slovakia.
  • Pardo C; Servicio de Aparato Digestivo, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Phillip V; Department of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
  • Pukitis A; Center of Gastroenterology, Hepatology and Nutrition, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Rasch S; Department of Internal Medicine II, University Hospital rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
  • Riekstina D; Center of Gastroenterology, Hepatology and Nutrition, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Rinja E; Clinical Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Ruiz-Rebollo ML; Servicio de Aparato Digestivo, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Sirtl S; Department of Medicine II, Ludwig Maximilians University Hospital, Munich, Germany.
  • Weingarten M; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Sandru V; Clinical Emergency Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Woitalla J; Department of Medicine II, University Hospital of Rostock, Rostock, Germany.
  • Ellenrieder V; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany.
  • Neesse A; Department of Gastroenterology, gastrointestinal Oncology and Endocrinology, University Medical Centre Goettingen, Goettingen, Germany albrecht.neesse@med.uni-goettingen.de.
Gut ; 73(3): 485-495, 2024 Feb 23.
Article en En | MEDLINE | ID: mdl-38129103
ABSTRACT

OBJECTIVE:

Early disease prediction is challenging in acute pancreatitis (AP). Here, we prospectively investigate whether the microbiome predicts severity of AP (Pancreatitis-Microbiome As Predictor of Severity; P-MAPS) early at hospital admission.

DESIGN:

Buccal and rectal microbial swabs were collected from 424 patients with AP within 72 hours of hospital admission in 15 European centres. All samples were sequenced by full-length 16S rRNA and metagenomic sequencing using Oxford Nanopore Technologies. Primary endpoint was the association of the orointestinal microbiome with the revised Atlanta classification (RAC). Secondary endpoints were mortality, length of hospital stay and severity (organ failure >48 hours and/or occurrence of pancreatic collections requiring intervention) as post hoc analysis. Multivariate analysis was conducted from normalised microbial and corresponding clinical data to build classifiers for predicting severity. For functional profiling, gene set enrichment analysis (GSEA) was performed and normalised enrichment scores calculated.

RESULTS:

After data processing, 411 buccal and 391 rectal samples were analysed. The intestinal microbiome significantly differed for the RAC (Bray-Curtis, p value=0.009), mortality (Bray-Curtis, p value 0.006), length of hospital stay (Bray-Curtis, p=0.009) and severity (Bray-Curtis, p value=0.008). A classifier for severity with 16 different species and systemic inflammatory response syndrome achieved an area under the receiving operating characteristic (AUROC) of 85%, a positive predictive value of 67% and a negative predictive value of 94% outperforming established severity scores. GSEA revealed functional pathway units suggesting elevated short-chain fatty acid (SCFA) production in severe AP.

CONCLUSIONS:

The orointestinal microbiome predicts clinical hallmark features of AP, and SCFAs may be used for future diagnostic and therapeutic concepts. TRIAL REGISTRATION NUMBER NCT04777812.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancreatitis / Microbioma Gastrointestinal Límite: Humans Idioma: En Revista: Gut Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancreatitis / Microbioma Gastrointestinal Límite: Humans Idioma: En Revista: Gut Año: 2024 Tipo del documento: Article País de afiliación: Alemania